KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 56 filers reported holding KRONOS BIO INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $96,882 | -4.6% | 78,131 | 0.0% | 0.02% | +25.0% |
| Q1 2024 | $101,570 | +4.0% | 78,131 | 0.0% | 0.02% | +6.7% |
| Q4 2023 | $97,664 | -3.8% | 78,131 | 0.0% | 0.02% | -51.6% |
| Q3 2023 | $101,570 | -24.4% | 78,131 | 0.0% | 0.03% | +29.2% |
| Q2 2023 | $134,385 | +17.8% | 78,131 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $114,071 | -9.9% | 78,131 | 0.0% | 0.02% | -11.1% |
| Q4 2022 | $126,572 | -51.7% | 78,131 | 0.0% | 0.03% | -55.7% |
| Q3 2022 | $262,000 | -7.7% | 78,131 | 0.0% | 0.06% | -19.7% |
| Q2 2022 | $284,000 | -49.7% | 78,131 | 0.0% | 0.08% | -46.5% |
| Q1 2022 | $565,000 | -46.8% | 78,131 | 0.0% | 0.14% | -31.1% |
| Q4 2021 | $1,062,000 | -35.2% | 78,131 | 0.0% | 0.21% | -19.8% |
| Q3 2021 | $1,638,000 | -12.5% | 78,131 | 0.0% | 0.26% | +11.3% |
| Q2 2021 | $1,871,000 | -61.5% | 78,131 | -53.0% | 0.23% | -74.2% |
| Q1 2021 | $4,866,000 | -2.0% | 166,250 | 0.0% | 0.90% | +79.8% |
| Q4 2020 | $4,966,000 | – | 166,250 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $3,428,989 | 3.75% |
| Wildcat Capital Management, LLC | 1,297,959 | $1,609,469 | 0.39% |
| Acuitas Investments, LLC | 443,457 | $549,887 | 0.29% |
| CM Management, LLC | 135,000 | $167,400 | 0.15% |
| Privium Fund Management (UK) Ltd | 292,182 | $341,853 | 0.13% |
| Alphabet Inc. | 1,438,232 | $1,783,408 | 0.09% |
| Forefront Analytics, LLC | 134,998 | $167,400 | 0.08% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 1,665,797 | $2,044,488 | 0.04% |
| Artal Group S.A. | 842,954 | $1,045,263 | 0.03% |
| VESTIA PERSONAL WEALTH ADVISORS | 15,718 | $19,490 | 0.02% |